Janus Henderson Investors
9 rounds tracked since 8 January 2026.
- Rounds
- 9
- Led
- 6
- Capital in these rounds
- $1.3B
Sectors
Countries
Rounds
- OMass Therapeutics $310MSeries C · 16 Oct
- Encoded TherapeuticsDevelops precision genetic medicines for severe neurological disorders as a clinical-stage biotechnology company. $275MSeries F · 9 Sept
- Triveni BioLeadDevelops novel antibody treatments for immunological and inflammatory disorders, including atopic dermatitis. $65MSeries C · 17 Jun
- Oak Hill BioLeadAcquires and develops rare disease drugs that big pharma has deprioritized. $32.5MSeries A · 1 Jun
- Ray TherapeuticsLeadDevelops treatments aimed at restoring vision in people with retinal disease. $125MSeries B · 21 Apr
- CalyxoLeadDevelops the CVAC system used for treating kidney stone removal in patients. $40MSeries F · 14 Apr
- ILiAD BiotechnologiesDevelops vaccines, including the BPZE1 pertussis vaccine candidate. $115MSeries B · 10 Feb
- Think BioscienceLeadDevelops small molecule drugs for historically challenging drug targets using synthetic biology. $55MSeries A · 20 Jan
- Parabilis MedicinesLeadDevelops oncology therapies, including FOG-001 (zolucatetide), using its Helicon platform. $305M8 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise